Progesterone enhanced remyelination in the mouse corpus callosum after cuprizone induced demyelination

Iranian Journal of Medical Sciences

Volumn 40, Issue 6, 2015, Pages 507-514

  Kashani, Iraj Ragerdi ^a   Hedayatpour, Azim ^a   Pasbakhsh, Parichehr ^a   Kafami, Laya ^b,c   Khallaghi, Behzad ^c   Malek, Fatemeh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Shefa Neuroscience Research Center   (Iran)

Author keywords

Multiple sclerosis; Progesterone; Remyelination

Indexed keywords

CUPRIZONE; MYELIN; MYELIN BASIC PROTEIN; PLACEBO; PROGESTERONE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; C57BL 6 MOUSE; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; DENSITOMETRY; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL STUDY; FEASIBILITY STUDY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR DYNAMICS; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; OLIGODENDROGLIAL PROGENITOR CELL; OUTCOME ASSESSMENT; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REMYELINIZATION; STEM CELL; WESTERN BLOTTING;

EID: 84943591581     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Acs P, Kipp M, Norkute A, Johann S, Clarner T, Braun A, et al. 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia. 2009;57:807-14. doi: 10.1002/glia.20806. PubMed PMID: 19031445.
2. Crawford DK, Mangiardi M, Song B, Patel R, Du S, Sofroniew MV, et al. Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain. 2010;133:2999-3016. doi: 10.1093/brain/awq237. PubMed PMID: 20858739; PubMed Central PMCID: PMC2947430.
3. Ibanez C, Shields SA, El-Etr M, Baulieu EE, Schumacher M, Franklin RJ. Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats. Neuropathol Appl Neurobiol. 2004;30:80-9. doi: 10.1046/j.0305-1846.2003.00515.x. PubMed PMID: 14720179.
4. Kipp M, Beyer C. Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis. Front Neuroendocrinol. 2009;30:188-200. doi: 10.1016/j.yfrne.2009.04.004. PubMed PMID: 19393685.
5. Houtchens MK. Pregnancy and multiple sclerosis. Semin Neurol. 2007;27:434-41. doi: 10.1055/s-2007-991127. PubMed PMID: 17940922.
6. Ye JN, Chen XS, Su L, Liu YL, Cai QY, Zhan XL, et al. Progesterone alleviates neural behavioral deficits and demyelination with reduced degeneration of oligodendroglial cells in cuprizone-induced mice. PLoS One. 2013;8:e54590. doi: 10.1371/journal.pone.0054590. PubMed PMID: 23359803; PubMed Central PMCID: PMC3554738.
7. Yu HJ, Fei J, Chen XS, Cai QY, Liu HL, Liu GD, et al. Progesterone attenuates neurological behavioral deficits of experimental autoimmune encephalomyelitis through remyelination with nucleus-sublocalized Olig1 protein. Neurosci Lett. 2010;476:42-5. doi: 10.1016/j.neulet.2010.03.079. PubMed PMID: 20381586.
8. Giatti S, Caruso D, Boraso M, Abbiati F, Ballarini E, Calabrese D, et al. Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis. J Neuroendocrinol. 2012;24:851-61. doi: 10.1111/j.1365-2826.2012.02284.x. PubMed PMID: 22283602.
9. Hussain R, El-Etr M, Gaci O, Rakotomamonjy J, Macklin WB, Kumar N, et al. Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors. Endocrinology. 2011;152:3820-31. doi: 10.1210/en.2011-1219. PubMed PMID: 21828184.
10. Garay L, Tungler V, Deniselle MC, Lima A, Roig P, De Nicola AF. Progesterone attenuates demyelination and microglial reaction in the lysolecithin-injured spinal cord. Neuroscience. 2011;192:588-97. doi: 10.1016/j.neuroscience.2011.06.065. PubMed PMID: 21736923.
11. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol. 2004;55:458-68. doi: 10.1002/ana.20016. PubMed PMID: 15048884.
12. Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001;11:107-16. doi: 10.1111/j.1750-3639.2001.tb00385.x. PubMed PMID: 11145196.
13. Gregg C, Shikar V, Larsen P, Mak G, Chojnacki A, Yong VW, et al. White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci. 2007;27:1812-23. doi: 10.1523/JNEUROSCI.4441-06.2007. PubMed PMID: 17314279.
14. Schumacher M, Guennoun R, Stein DG, De Nicola AF. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther. 2007;116:77-106. doi: 10.1016/j.pharmthera.2007.06.001. PubMed PMID: 17659348.
15. Zendedel A, Beyer C, Kipp M. Cuprizoneinduced demyelination as a tool to study remyelination and axonal protection. J Mol Neurosci. 2013;51:567-72. doi: 10.1007/s12031-013-0026-4. PubMed PMID:23666824.
16. Clarner T, Diederichs F, Berger K, Denecke B, Gan L, van der Valk P, et al. Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions. Glia. 2012;60:1468-80. doi: 10.1002/glia.22367. PubMed PMID: 22689449.
17. Steelman AJ, Thompson JP, Li J. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication. Neurosci Res. 2012;72:32-42. doi: 10.1016/j.neures.2011.10.002. PubMed PMID: 22015947; PubMed Central PMCID: PMC3230728.
18. Schumacher M, Guennoun R, Ghoumari A, Massaad C, Robert F, El-Etr M, et al. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr Rev. 2007;28:387-439. doi: 10.1210/er.2006-0050. PubMed PMID: 17431228.
19. Labombarda F, Gonzalez SL, Lima A, Roig P, Guennoun R, Schumacher M, et al. Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury. Glia. 2009;57:884-97. doi: 10.1002/glia.20814. PubMed PMID: 19053058.
20. Garay LI, Gonzalez Deniselle MC, Brocca ME, Lima A, Roig P, De Nicola AF. Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis. Neuroscience. 2012;226:40-50. doi: 10.1016/j.neuroscience.2012.09.032. PubMed PMID: 23000619.
21. El-Etr M, Ghoumari A, Sitruk-Ware R, Schumacher M. Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids. Maturitas. 2011;68:47-51. doi: 10.1016/j.maturitas.2010.09.014. PubMed PMID: 21035281.
22. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev. 2001;81:871-927. PubMed PMID: 11274346.